ACT Capital Management’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $853K | Hold |
156,250
| – | – | 1.18% | 19 |
|
|
2022
Q2 | $696K | Sell |
156,250
-23,167
| -13% | -$103K | 0.97% | 23 |
|
|
2022
Q1 | $1.59M | Hold |
179,417
| – | – | 1.69% | 14 |
|
|
2021
Q4 | $1.58M | Buy |
179,417
+11,084
| +7% | +$97.7K | 1.14% | 21 |
|
|
2021
Q3 | $1.92M | Buy |
168,333
+22,500
| +15% | +$257K | 0.99% | 22 |
|
|
2021
Q2 | $2.45M | Buy |
+145,833
| New | +$2.45M | 1.26% | 16 |
|